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Many  medicinal  herbs  are  used  in folk  medicine  without  taking  into  account  their  toxicity.  Hamelia  patens
Jacq.  (Rubiaceae),  a Mexican  endemic  species,  is  used  for  the  empirical  treatment  of pain.  The  aim  of this
work was  to evaluate  the  toxicity  and antinociceptive  effects  of  ethanolic  extracts  of H.  patens  leaves.
The  toxicity  of  H. patens  leaves  (500–5000  mg/kg)  was  evaluated  in acute  (14 days)  and  subacute  (28
days)  assays.  In the subacute  assay,  a blood  analysis  (both  hematology  and  chemistry)  was  carried  out.
The  antinociceptive  effects  of  H. patens  leaves  (50–200  mg/kg)  were  evaluated  using thermal-induced
nociception  (hot plate)  and  the  chemical-induced  nociceptive  tests  (acid  acetic  and  formalin).  In  the
acute  toxicity  test,  the  LD50 estimated  for H. patens  leaves  was  2964  mg/kg  i.p.  and  >5000  mg/kg  p.o.,
whereas  in  the  subacute  test  HPE  did not  affect  hematological  or biochemical  parameters.  In chemical-as chromatography–mass spectrometry
raditional medicine induced  nociception  models,  H. patens  (100  and  200  mg/kg  p.o.)  showed  antinociceptive  effects  with
similar  activity  than 100  mg/kg  naproxen.  In  the  hot  plate  test,  HPE  at 100  mg/kg  (17%) and  200  mg/kg
(25%)  showed  moderate  antinociceptive  effects.  HPE  could  be a good  source  of antinociceptive  agents
because  of  its good  activity  and  low  toxicity.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Worldwide, there is an increasing interest for using medici-
al plants for the prevention and treatment of many diseases.
he general population perceives herbal medicines as safe because
f their natural origin, their efﬁcacy and their long use in tradi-
ional medicine. Nevertheless, many plant extracts are used in folk
edicine without taking into account their toxicity aspect.
Hamelia patens Jacq., (Rubiaceae), commonly known as
bayetilla,” “trompetilla,” “coralillo,” or “hierba coral, is a bush
idely distributed in tropical areas of the American continent.
. patens has shown antidiarrheal (Pérez et al., 1996), anti-
nﬂammatory (Sosa et al., 2002), cytotoxic (Taylor et al., 2013),
ound healing (Gomez-Beloz et al., 2003), antifungal (Abubacker
t al., 2013), antibacterial (Camporese et al., 2003) and vasorelaxant
Reyes-Chilpa et al., 2004) properties. The chemical constituents
solated from this plant are pteropodine, isopteropodine, iso-
aruquine, maruquine, narirutin, palmirine, rosmarinic acid,
umberine, (−)-hameline, tetrahydroalstonine, aricine, uncarine F,
∗ Corresponding author.
E-mail: candy.carranza@uaslp.mx (C. Carranza-Álvarez).
http://dx.doi.org/10.1016/j.bjp.2015.03.007
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorastigmast-4-ene-3, 6-dione and 5,7,2′,5′-tetrahydroxyﬂavanone 7-
rutiroside (Aquino et al., 1990; Ahmad et al., 2012; Paniagua-Vega
et al., 2012).
In traditional medicine, H. patens is used as diuretic and for
the empirical treatment of pain, inﬂammation, rheumatism, dia-
betes, wound healing, gastritis, stomach ache, snake and scorpion
bites, fever and others (Coe and Anderson, 1999; Leonti et al., 2001;
Andrade-Cetto, 2009; Ahmad et al., 2012). Nevertheless, the toxic-
ity and antinociceptive effects of H. patens remain to be studied.
In Mexican traditional medicine there are many plants that
remain to be studied in terms of their chemical, biological and
pharmacological properties. As part of our validation of pharma-
cological effects in Mexican medicinal plants, this study presents
that H. patens shows low toxicity and exerts antinociceptive effects.
Materials and methods
ReagentsNaproxen sodium was  obtained from Tripharma (Distrito Fed-
eral, Mexico). N,O-bis (trimethylsilyl) triﬂuoroacetamide (BSTFA)
was acquired from Sigma Aldrich (St Louis, MO,  USA). Buprenor-
phine (BNP) was  from Schering Plough Mexico (Distrito Federal,
 Ltda. All rights reserved.
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exico). Ketamine and xylazine were obtained from Pisa
gropecuaria (Atitalaquia, Hidalgo, Mexico).
lant material
Hamelia patens Jacq., Rubiaceae, was collected in the municipal-
ty of Axtla de Terrazas, located at 21◦ 26′ north latitude and 98◦ 52′
est longitude in the southeastern portion of the state of San Luis
otosi, Mexico. A voucher specimen (HPHP-SP-102) was  deposited
t Centro de Investigación de la reserva de la biosfera de Mapimi.
reparation of ethanol extract of H. patens leaves (HPE)
Powdered dry leaves of H. patens (20 g) were extracted with
thanol using a Soxtherm apparatus (Soxtherm automatic, Ger-
adt, Germany) for 4 h. The extract was ﬁltered by an acrodisk
ylon membrane 0.45 mm pore size (Gelman Sciences, Northamp-
on, UK). The solvent was evaporated to dryness in a vaccum rotator
vaporator below 60 ◦C. The residue was protected from light.
ample preparation for gas chromatography–mass spectrometry
GC–MS) analysis
Approximately 10 mg  of HPE was transferred to polyethylene
ube and dissolved with 2 ml  isooctane. For silylation, 100 l of
STFA was added to the samples and incubated at 100 ◦C for 10 min
n a CEM Discover microwave equipment at 150 W,  290 psi.
C–MS analysis
Analysis of the HPE was performed on gas chromatograph 6890
Agilent Technology, Santa Clara, CA, USA) with a selective mass
etector 5973. DB-5HT column (15 m × 0.25 mm ID, 0.10 m ﬁlm
hickness) was used for the analysis. The operating conditions of
he column were as follows: oven temperature programmed from
00 ◦C (3 min) to 320 ◦C at 15 ◦C/min, and 2 min  hold. The injector
emperature was maintained at 320 ◦C and the volume of injected
ample was 1 l. The MS  ran in electron impact at 71 eV and Mass
pectral data were acquired in the scan mode in the m/z range
3–800. The identiﬁcation of compounds was performed by com-
aring their mass spectra with data from NIST 11 (National Institute
f Standards and Technology, USA), WILEY 09.
nimals
Balb/c or C57BL/6 male mice weighing 25–30 g or Wistar male
ats weighing 150–200 g, from the Universidad Autónoma de San
uis Potosi animal facility, were housed in isolated cages at 24 ◦C
nder a light–dark cycle of 12:12. The animals were supplied
ith food and water ad libitum.  The experiments were carried out
ccording to Ofﬁcial Mexican Norm NOM 062-ZOO-1999 (techni-
al speciﬁcations for the production, care and use of laboratory
nimals). The research also followed the Guidelines on Ethi-
al Standards for Investigations of Experimental Pain in Animals
Zimmerman, 1983).
cute toxicity test
Six weeks old C57BL/6 mice were used. The acute toxicity
est of the HPE, i.p.  or p.o. administration, and the selection of
oses was performed according to the method described by Lorke
1983). Mice (n = 5 per group) received HPE at doses of 500, 1000.
500, 3700 and 5000 mg/kg and the control group received saline
olution. Mice were observed daily during 14 days for mortality,
ehavioral changes and other toxic signs. Body weight of mice was
ecorded at the beginning and end of the experiment. The dosee Farmacognosia 25 (2015) 170–176 171
leading to 50% death (LD50) in mice was  calculated by regression
analysis (percent death vs. log dose).
Subacute toxicity test
Eight week old Wistar rats (n = 10 per group) were used. HPE
was administered orally at doses of 500, 1000, 2500, 3700 and
5000 mg/kg daily during 28 days. The control group consisted of
rats administered with saline solution. Body weight of rats was
recorded throughout the study. At the end of the experiment, rats
were fasted overnight and anesthetized with a single intraperi-
toneal application of ketamine (50 mg/kg) and xylazine (12 mg/kg),
for blood collection by cardiac puncture.
Blood analysis
Blood samples were collected into heparinized and non-
heparinized centrifuge tubes. A blood analysis (both hematology
and chemistry) was  carried out. The heparinized blood was
used for a hematological study which included the estimation
of white blood cells (WBC) and differential leukocyte counts,
platelet, hematocrit and hemoglobin (Hb). The non-heparinized
blood was  allowed to coagulate before being centrifuged and
the serum was separated. Hematological analysis was  performed
using an automatic hematological analyzer (XT-1800i, Sysmex,
Mundelein, IL, USA). The parameters of blood samples were: red
blood cells (RBC), hematocrit (HCT), mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), and mean corpuscu-
lar hemoglobin concentration (MCHC), neutrophils, lymphocytes,
monocytes, eosinophils and basophils. Biochemical analysis of
serum samples was  performed using an automatic chemistry ana-
lyzer (Vitros 250, Ortho Clinical Diagnostics, Rochester, NY, USA).
The biochemical parameters measured were: glucose, creatinine,
blood urea nitrogen (BUN), alkaline phosphatase (ALP), alanine
aminotransferase (ALT), aspartate aminotransferase (AST), glucose,
creatinine and glycated hemoglobin (HbA1c).
Antinociceptive assays
Hot plate
For antinociceptive tests, Balb/c mice (n = 8 per group) were
used. The hot plate test was conducted on a thermostatically con-
trolled heated metal plate at a temperature of 55 ± 1 ◦C, according
to the method of Turner (1965). The time (in s) that elapsed
between placing the mouse on the hot plate and the manifesta-
tion of signs of acute discomfort such as licking of the hind paw
or jumping in an attempt to escape from the heat was  taken as
the reaction time or latency. Mice exhibiting latency time between
10 and 20 s were chosen. The latency time was determined at 60,
120 and 240 min  after the application of the following test samples
(n = 8 each group): vehicle (saline solution), BNP (1 mg/kg i.p.)  or
HPE (50, 100 and 200 mg/kg p.o.). A cut off time of 45 s was allowed
to avoid thermal injury to the paws. The antinociceptive response
was calculated according to the following formula:
% Antinociceptive response
= Reaction time − basal latency
Cut off latency − basal latency × 100
Formalin
The formalin test was  carried out as described by Hunskaar and
Hole (1987). One hour prior to formalin injection, mice (n = 8 per
group) orally received 100 mg/kg NPX, HPE at doses of 50, 100
and 200 mg/kg and saline solution (the vehicle group). Mice were
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Table  1
Effect of HPE on hematological parameters on subacute toxicity test in rats.
Parameter Control HPE mg/kg
500 1000 2500 3700 5000
RBC (106/ml) 9.62 ± 0.54 9.97 ± 0.22 9.11 ± 0.92 9.45 ± 0.27 8.82 ± 0.20 8.84 ± 0.14
Hb  (g/dl) 17.93 ± 0.93 17.47 ± 0.47 16.17 ± 1.17 16.47 ± 0.38 15.40 ± 0.30 15.43 ± 0.38
HCT  (%) 48.13 ± 2.73 49.00 ± 1.45 48.53 ± 4.37 47.80 ± 0.60 45.17 ± 0.87 44.13 ± 1.0
MCV  (fL) 50.03 ± 0.67 49.13 ± 0.59 53.30 ± 0.70 50.57 ± 0.95 51.23 ± 0.31 49.93 ± 1.31
MCH  (pg) 17.93 ± 0.32 17.50 ± 0.26 17.87 ± 0.29 17.43 ± 0.12 17.47 ± 0.23 17.50 ± 0.46
MCHC  (g/dl) 35.80 ± 0.20 35.63 ± 0.25 33.47 ± 0.59 34.43 ± 0.42 34.10 ± 0.26 35.0 ± 0.10
Platelets  (103/l) 1074 ± 50.48 977.7 ± 27.06 1022.3 ± 81.8 870.3 ± 21.2 847.6 ± 93.4 757.8 ± 84.4
WBC  (106) 2.61 ± 0.49 2.65 ± 0.80 5.39 ± 0.24* 3.22 ± 1.89 2.05 ± 0.58 2.04 ± 0.21
Neutrophils (%) 19.67 ± 4.50 23.23 ± 5.06 15.00 ± 2.77 14.03 ± 4.37 33.83 ± 5.25* 25.53 ± 2.58
Lymphocytes (%) 72.93 ± 2.92 71.60 ± 6.01 78.90 ± 6.60 72.50 ± 15.23 63.30 ± 6.60 70.37 ± 3.74
Monocytes (%) 2.70 ± 0.35 4.37 ± 1.99 3.23 ± 2.67 3.03 ± 2.35 1.87 ± 1.15 3.50 ± 1.18
Eosinophils (%) 1.13 ± 0.21 0.97 ± 0.74 1.53 ± 0.43 1.17 ± 0.50 0.43 ± 0.40 0.47 ± 0.06
Basophils (%) 0.23 ± 0.11 0.23 ± 0.11 0.33 ± 0.13 0.17 ± 0.15 0.57 ± 0.17 0.23 ± 0.13
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BBC, red blood cells; Hb, hemoglobin; HCT, hematocrit; MCV, mean corpuscular
oncentration; WBC, white blood cells.
* Statistically different from the control group (ANOVA followed by Tukey, p ≤ 0.0
njected with 30 l of 1% formalin (in 0.9% saline) into the subplan-
ar space of the right hind paw, and individually placed into glass
ylinders. The duration of paw licking was recorded at 0–15 min
ﬁrst phase) and 15–45 min  (second phase) after formalin injection.
cetic acid-induced writhing
The acetic acid method was carried out as described by Koster
t al. (1959). One hour prior to acetic acid injection, mice (n = 8 per
roup) orally received 100 mg/kg NPX, HPE at doses of 50, 100 and
00 mg/kg and saline solution (the vehicle group). Each group was
dministered 10 ml/kg body weight (i.p.) of an aqueous solution
f acetic acid (1.0%). The mice were individually placed into glass
ylinders and observed for the number of abdominal constrictions
nd stretching, counted over a period of 0–30 min.
tatistical analysis
All experimental values are expressed as the mean ± the
tandard deviation of at least two independent experiments. Statis-
ically signiﬁcant differences from the vehicle group were identiﬁed
y Student’s t-test or ANOVA with post hoc Tukey test for paired
ata. The level of p ≤ 0.05 was used to determine statistical signiﬁ-
ance. All calculations were performed using the Graph Pad Prism
.3 software system (GraphPad Software, San Diego, CA, USA).
esults
hemical composition of HPEThe chromatogram of HPE using GC–MS showed the presence
f several components (Fig. 1A), including polyphenol (catechin),
ydroxycinnamic acid (caffeic acid), cyclohexane carboxylic acids
able 2
ffect of HPE on biochemical parameters on subacute toxicity test in rats.
Control 
500 1000 
Glucose (mg/dl) 132.67 ± 11.93 110 ± 17.69 171.67 ± 
HbA1c  (%) 3.2 ± 0.20 3.17 ± 0.06 3.50 ± 
BUN  (mg/dl) 63.20 ± 5.11 54.20 ± 4.53 54.23 ± 
Creatinine (mg/dl) 0.27 ± 0.11 0.23 ± 0.06 0.40 ± 
AST  (U/l) 103.00 ± 31.18 114.33 ± 28.59 90.43 ± 
ALT  (U/l) 116.33 ± 53.25 83.00 ± 13.0 47.00 ± 
ALP  (U/l) 137.77 ± 34.27 144.67 ± 19.50 188.67 ± 
UN, blood urea nitrogen; ALT, alanine aminotransferase; ALP, alkaline phosphatase; AST
* Statistically different from the control group (ANOVA followed by Tukey, p ≤ 0.05).e; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin
(shikimic acid and quinic acid), diterpene (phytol), phytosterol
(-sitosterol), triterpenes (squalene, oleanolic acid, ursolic acid),
tocopherols and alkaloid (mitraphylline) (Fig. 1B). The most abun-
dant component was  ursolic acid (40%) (Fig. 1B).
Acute toxicity
The LD50 estimated by the Lorke method (1983) was 2964 mg/kg
i.p.  and >5000 mg/kg p.o. At doses of 2500 mg/kg (i.p. or p.o.) or
higher, neurological deﬁcit was  observed in the mice only in the
ﬁrst 4 h after treatment. The symptoms included immobility and
sedation. HPE tested at any concentration, administered orally or
intraperitoneally, lacked of toxic effects in body weight of mice. An
autopsy at the end of the experimental period revealed no apparent
changes in organs.
Subacute toxicity
Hematological parameters
HPE at dose of 1000 mg/kg increased signiﬁcantly (p ≤ 0.05)
the WBC  count. Similarly, 3700 mg/kg HPE caused a signiﬁcant
(p ≤ 0.05) increase in the neutrophil count. Other hematological
parameters were not changed by the application of HPE (Table 1).
Biochemical parameters
The data indicated that BUN decreased (p ≤ 0.05) in rats treatedwith 5000 mg/kg HPE. The levels of AST decreased (p ≤ 0.05) in rats
treated with 3700 mg/kg HPE, whereas the levels of ALP increased
(p ≤ 0.05) in the group of 2500 mg/kg HPE. Other biochemical
parameters were not altered by the administration of HPE (Table 2).
HPE (mg/kg)
2500 3700 5000
43.36 128.33 ± 42.71 104.67 ± 12.22 155.57 ± 82.97
0.00 3.40 ± 0.00 3.26 ± 0.00 3.36 ± 0.00
7.25 58.37 ± 3.55 65.20 ± 9.43 36.67 ± 4.35*
0.00 0.33 ± 0.06 0.40 ± 0.00 0.60 ± 0.35
7.02 147.67 ± 18.56 124.00 ± 15.62 103.00 ± 17.28
16.64 87.67 ± 17.74 20.33 ± 2.89* 30.33 ± 1.53
29.67 229.00 ± 29.72* 150.23 ± 31.37 118.67 ± 19.01
, aspartate aminotransferase; HbA1c, glycated hemoglobin.
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A
B
Constituents Retention 
time
%
glycerol 1.61 2.25
malic acid 4.44 0.11
shikimic acid 7.40   0.63
hexadecanoic acid 8.71   1.16
caffeic acid 9.33   0.17
phytol 9.51 0.48
α-linolenic acid 9.72 1.66
octadecanoic acid 9.89   0.47
dehydroabietic acid 10.57 0.40
bis (3-tert-butyl-2-hydroxy-5-methylphenyl) methane 10.74  0.29
squalene 12.79 4.52
catechin 13.19  3.02
-tocopherol 13.59 0.25
mitraphylline 13.65  4.02
-tocopherol 14.17  1.29
campesterol 14.57 2.67
-sitosterol 14.92  2.92
1-triacontanol 15.00 0.59
oleanolic acid 15.78 6.58
ursolic acid 15.97 40.59
1500000
1400000
1300000
1200000
1100000
1000000
900000
800000
700000
600000
500000
400000
300000
200000
100000
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00
stitue
H
i
s
(
gFig. 1. GC–MS chromatogram (A) and chemical con
PE exerts antinociceptive effects
HPE showed good antinociceptive activity in two  of the three
n vivo models. In the hot plate test at 60 min  of treatment, HPE
howed the highest antinociceptive effects by 6% (50 mg/kg), 17%
100 mg/kg) and 25% (200 mg/kg), in comparison to the vehicle
roup (Fig. 2A). After 120 min, the antinociceptive effect of HPEnts (B) of ethanol extract of H.  patens leaves (HPE).
decreased. On the contrary, the highest antinociceptive effects
(70%) of BNP (1 mg/kg) were shown at 120 min  of treatment. These
effects remained up to the end of the experiment (Fig. 2A).In the formalin test at phase 1 and phase 2, HPE decreased sig-
niﬁcantly (p ≤ 0.05) the licking time, compared to the vehicle group
(Fig. 2B). In the phase 1, HPE exerted antinociceptive effects by 19%
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Fig. 2. HPE exerts antinociceptive effects. The antinociceptive effects of HPE
(50–200 mg/kg) were evaluated using thermal-induced nociception hot plate (A),
and the chemical-induced nociceptive tests formalin (B) and acid acetic (C). The
positive control BNP (1 mg/kg) was used for the hot plate test, whereas the positive
control NPX (100 mg/kg) was  used for the formalin and acid acetic tests. Results
represent the mean ± standard deviation (SD). ** denotes p ≤ 0.05, compared to the
vehicle group.e Farmacognosia 25 (2015) 170–176
(50 mg/kg), 30% (100 mg/kg) and 39% (200 mg/kg), respectively,
whereas in the phase 2 the antinociceptive effects of HPE were
60% (50 mg/kg), 69% (100 mg/kg) and 75% (200 mg/kg) (Fig. 2B). The
antinociceptive effects of HPE were comparable with those found
by the positive control 100 mg/kg NPX, which showed antinocicep-
tive effects by 48% (phase 1) and 74% (phase 2) (Fig. 2B).
In the acid acetic test, HPE decreased signiﬁcantly (p ≤ 0.05) the
number of writhings in a dose dependent manner, compared to
the vehicle group (Fig. 2C). The maximum percentage inhibition of
acetic acid-induced abdominal constrictions by HPE was found at
100 mg/kg (57%) and 200 mg/kg (65%). This effect was  comparable
to 100 mg/kg NPX (70%) (Fig. 2C).
Discussion
Hamelia patens Jacq., (Rubiaceae), is used in traditional medicine
for the empirical treatment of pain (Ahmad et al., 2012). Nev-
ertheless, the antinociceptive effects of H. patens as well as
its toxicity remain to be studied. Toxicity tests are commonly
used in the preliminary studies of medicinal plants to detect
pharmacological activities (Malone and Robichaud, 1962). In this
study, the toxicity of H. patens in acute and subacute assays was
recorded.
In our knowledge, this is the ﬁrst report that indicates the chem-
ical composition of ethanol extract from H. patens leaves using
GC–MS. The compounds found in HPE had not been previously
reported.
In the acute toxicity test, if no mortality is observed at the dose
of 5.0 g/kg, the drug tested can be considered as not toxic (Hayes,
1989). The results indicated that HPE orally administered could be
considered as non-toxic. Nevertheless, HPE administered intraperi-
toneally could be considered as moderate toxic. The reduction in
body weight is a simple and sensitive index of toxicity. The data
indicated that there were no changes of body weight in mice treated
with HPE.
Several hematological and biochemical parameters were esti-
mated in the subacute toxicity test in rats to evaluate the safe use
of H. patens.  The results indicated that HPE did not induce anemia
or disturbances in the erythrocytes or in the hemoglobin produc-
tion. Although there was an increase in WBC  (1000 mg/kg HPE) and
neutrophils (3700 mg/kg HPE), the values are in the physiological
limits described for the species (Harkness and Wagner, 1993). The
increase of neutrophils may  be the result of the administration of
HPE as a physiological response against foreign compounds, which
might be a normal response from rat organism. In rats treated with
HPE there were no changes in the other hematologic parameters.
These ﬁndings suggest that H. patens did not induce hematologic
alterations.
The levels of serum glucose and glycated hemoglobin were also
evaluated. These two parameters were not signiﬁcantly changed
in all the groups. Therefore, HPE does not affect the carbohydrate
metabolism.
Renal function was  evaluated by means of urea and creatinine
serum levels. Renal damage is considered when both urea and cre-
atinine are increased concomitantly (Satyanarayana et al., 2001).
The level of urea decreased in the rats treated with 5000 mg/kg
HPE. However, the values are in the physiological limits of rat specie
(Harkness and Wagner, 1993).
Hepatic function is commonly monitored by the evaluation of
the serum level of transaminases ALT, AST and ALP. Although there
was an increase of ALP in HPE at 2500 mg/kg, it has been described
that a ﬁve-fold higher increase in ALP level is considered as mod-
erate or acute hepatic toxicity. Increases lower than ﬁve-fold are
considered as no relevant (Wingard et al., 2000). Therefore, treat-
ment with HPE does not alter hepatic function in rats.
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Together, the results indicate that H. patens could be consid-
red as a non-toxic plant. Nevertheless, other studies including the
utagenic, genotoxic and carcinogenic effects of HPE should be
erformed. In addition, a subchronic toxicity test should be con-
ucted to establish the adverse effects of a repeated response to H.
atens.
Nociception is a mechanism by which noxious stimuli are trans-
itted to the central nervous system (CNS). The nociceptors are
ain-sensitive neurons located in the skin, vessels, muscles, fas-
ia, joints and viscera (Calixto et al., 2000). In spite the use of
any analgesics, it is needed to ﬁnd new antinociceptive drugs
ith higher or similar efﬁcacy and potency than current analgesics
ut with less toxic effects. Three models were used in this study
o evaluate the antinociceptive actions of H. patens.  One model
f thermal-induced nociception (hot plate) and two models of
hemical-induced nociception (acid acetic and formalin). The doses
f HPE used to evaluate its antinociceptive effects were selected
ased on the following aspects: (1) their lack of toxic effects as
valuated in acute and subacute toxicity tests, (2) on prelimi-
ary studies carried out in our laboratory and (3) to analyze the
ntinociceptive activity of HPE (50–200 mg/kg) compared to NPX
100 mg/kg).
The hot-plate test is a predominantly a spinal reﬂex that eval-
ates centrally acting antinociceptive agents (Turner, 1965). The
esults suggest that HPE might not induce central antinociceptive
ffects because HPE increased moderately the latency time in this
odel.
The formalin test is considered a model of persistent pain pro-
uced in two phases. The ﬁrst phase (0–15 min) is characterized
y neurogenic pain and the second phase (15–45 min) is charac-
erized by inﬂammatory pain (Hunskaar and Hole, 1987). In this
odel, centrally acting drugs inhibited both phases, while periph-
ral acting drugs inhibited mainly the second phase. HPE decreased
he pain mainly in the second phase.
Acetic acid is an inducer of abdominal contractions and
wisting of abdominal muscles by the increase in the level of
ro-inﬂammatory agents (interleukin-1,  tumor necrosis factor-
 and interleukin-8) in the peripheral tissue ﬂuid (Ikeda et al.,
001). This pain model is used for evaluating peripherally act-
ng antinociceptive agents (Ikeda et al., 2001). In this study,
PE at the doses of 50, 100 and 200 mg/kg signiﬁcantly reduced
he number of writhing episodes in mice, indicating the inhi-
ition of acetic acid-induced visceral nociception. These results
uggest that HPE might exert peripheral antinociceptive effects.
n the chemical-induced nociceptive tests, H. patens showed
ntinociceptive effects with similar activity than 100 mg/kg
PX.
Ursolic acid, the most abundant component (40%) found in HPE,
as been shown to exert antinociceptive effects in different models
Tapondjou et al., 2003; González-Trujano et al., 2012; Rodrigues
t al., 2012). The good antinociceptive effects of HPE could be due
he presence of ursolic acid. Nevertheless, further studies are neces-
ary to evaluate the electrophysiological, anatomical and molecular
echanisms by which H. patens exerts its antinociceptive effects.
he results here presented validate the traditional use of H. patens
or the treatment of pain.
onclusions
HPE shows low toxicity in acute and subacute tests. H. patens
xerts antinociceptive effects with similar activity than 100 mg/kg
PX in chemical-induced nociception models. Therefore, this plant
ould be a good source of antinociceptive agents because of its good
ctivity and low toxicity. In addition, it is interesting to evaluate the
ntinociceptive effect of H. patens constituents.e Farmacognosia 25 (2015) 170–176 175
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